Zymeworks Presents Preclinical Data for ZW1528, a Novel Bispecific Antibody for Respiratory Inflammation

Zymeworks announced the presentation of preclinical data for ZW1528, a novel bispecific molecule targeting IL-4Rα and IL-33, at the American Thoracic ...
Home/KnloSights/Clinical Trial Updates/Zymeworks Presents Preclinical Data for ZW1528, a Novel Bispecific Antibody for Respiratory Inflammation